Cambria Cannabis ETF (TOKE)

Delayed Data
As of Jan 14
 -0.14 / -1.14%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks capital appreciation from investments in the global equity markets that have exposure to the broad cannabis industry. Under normal market conditions, at least 80% of the value of the fund's net assets (plus borrowings for investment purposes) will be invested in Cannabis Companies. The Advisor generally expects to invest in Cannabis Companies across a broad market capitalization spectrum of micro-, small-, and mid-capitalization stocks.

No recent news for Cambria Cannabis ETF.


1 month+0.16% 3 years--
3 months-12.58% 5 years--
1 year-32.46% Since inception-22.01%
Data through 01/15/2022

Quote Details

Previous close$12.24
Open day’s range12.10 – 12.24
Net asset value (NAV)12.23 (01/14/2022)
Daily volume12,869
Average volume (3 months)16,214
Data as of 4:00pm ET, 01/14/2022

Peer Comparisonvs. Miscellaneous sector ETFs

Performance 5-yr return--+13.67%
Expense Gross exp ratio0.59%--
Risk 5 year sharpe ratio----
Net assets$24.9M--
Average market cap$5.3B$14.9B
Average P/E18.125.4
Dividend / Share--0.08%


No competitors data available.


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
IIPR Innovative Industrial Properties Inc12.98%
ARNA Arena Pharmaceuticals Inc8.65%
-- 8.32%
STZ Constellation Brands Inc8.12%
SMG Scotts Miracle-Gro Co6.20%
-- 4.80%
-- 4.74%
JAZZ Jazz Pharmaceuticals PLC4.50%
PM Philip Morris4.40%
TPB Turning Point Brands Inc4.26%